Cialis Vaccine Interaction Profile: What Tadalafil Users Need to Know

Does Tadalafil Interact With Vaccines?

No vaccine approved by the FDA produces a pharmacokinetic or pharmacodynamic interaction with tadalafil. Vaccines work through antigen presentation and immune-cell activation. Tadalafil works by inhibiting cyclic GMP degradation in vascular smooth muscle. These two mechanisms do not share a pathway.

The FDA-approved prescribing information for Cialis lists the following interaction categories: organic nitrates, alpha-adrenergic antagonists (alpha-blockers), antihypertensives, riociguat (a soluble guanylate cyclase stimulator), alcohol, CYP3A4 inhibitors, CYP3A4 inducers, and other PDE5 inhibitors. [1] Vaccines appear nowhere in that document.

Why the Question Arises

Patients starting tadalafil often schedule routine health appointments at the same time, which means flu shots, shingles vaccines (Shingrix), COVID-19 boosters, and pneumococcal vaccines (Prevnar 20) may coincide with a new prescription. The timing question is understandable. Getting vaccinated while taking tadalafil carries no known clinical risk based on the published pharmacology of the drug. [2]

What the Label Actually Says

The Cialis prescribing information states that "the combination of tadalafil and nitrates" is contraindicated and that "co-administration with alpha-blockers" requires dose adjustment. [1] The document contains no language restricting vaccination timing. That absence is itself clinically meaningful: the FDA requires disclosure of all known interactions in the label.

Immunological Considerations

Tadalafil has been studied in pulmonary arterial hypertension (PAH) patients who are often immunocompromised by underlying conditions. A 2009 trial (PHIRST-1, N=405) examined tadalafil 40 mg once daily in PAH and found no signal of immune suppression that would compromise vaccine response. [3] PDE5 inhibitors do not suppress T-cell proliferation, B-cell antibody production, or antigen-presenting cell function at therapeutic doses. [4]

How Tadalafil's Pharmacology Shapes Its Interaction Risk

Tadalafil selectively inhibits phosphodiesterase type 5, the enzyme that degrades cyclic guanosine monophosphate (cGMP) in smooth muscle cells. Elevated cGMP causes vasodilation. [1] The clinical interaction risks that follow from this mechanism are almost entirely cardiovascular and CYP450-related.

CYP3A4 Metabolism

Tadalafil is metabolized primarily by CYP3A4 in the liver. Strong CYP3A4 inhibitors significantly increase tadalafil plasma concentrations. The FDA label specifies that ketoconazole 400 mg daily increased tadalafil AUC by 312% and Cmax by 22%. [1] Ritonavir 200 mg twice daily increased tadalafil AUC by 124%. [1] These are the interactions that require dose capping (maximum 10 mg tadalafil every 72 hours with ritonavir). [1]

No vaccine alters CYP3A4 activity at clinically meaningful levels in healthy adults. A 2006 study in Clinical Pharmacology and Therapeutics found that influenza vaccination produced transient cytokine release but did not produce sustained CYP3A4 inhibition sufficient to alter drug exposure. [5]

Nitrate Contraindication

This is the most dangerous interaction on the tadalafil label. Concurrent use of any organic nitrate (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite) is absolutely contraindicated because both agents lower blood pressure through cGMP-mediated pathways, and the combination can cause life-threatening hypotension. [1] The FDA label states: "Do not use CIALIS in patients who are taking any form of organic nitrate." [1]

Vaccines contain no nitrate compounds.

Alpha-Blocker Additive Hypotension

Alpha-blockers (tamsulosin, doxazosin, alfuzosin, terazosin) prescribed for BPH or hypertension also lower blood pressure. The label requires that patients be stable on alpha-blocker therapy before starting tadalafil, and it recommends initiating tadalafil at the lowest dose (2.5 mg or 5 mg). [1] In a study of 18 healthy men, tadalafil 20 mg combined with doxazosin 8 mg produced a mean maximum decrease in standing systolic blood pressure of 9 mmHg compared with doxazosin alone. [6]

Again, vaccines play no role in this interaction class.

Clinically Significant Tadalafil Drug Interactions: A Full Review

Understanding what does interact with tadalafil helps contextualize why vaccines do not appear on the radar.

Strong CYP3A4 Inhibitors (Dose Adjustment Required)

| Drug | Interaction Magnitude | FDA Label Guidance | |---|---|---| | Ketoconazole 400 mg/day | AUC +312% | Max 10 mg per dose | | Itraconazole 200 mg/day | AUC +312% (estimated) | Max 10 mg per dose | | Ritonavir 200 mg BID | AUC +124% | Max 10 mg q72h | | Clarithromycin | Significant increase expected | Use with caution |

[1]

CYP3A4 Inducers (Reduced Efficacy)

Rifampin 600 mg daily decreased tadalafil AUC by 88% in a dedicated pharmacokinetic study. [1] Patients on rifampin for tuberculosis or other indications should expect substantially reduced tadalafil efficacy. Other inducers (carbamazepine, phenytoin, phenobarbital, St. John's Wort) produce similar reductions through the same mechanism. [1]

Antihypertensives

Tadalafil 20 mg combined with amlodipine 5 mg or 10 mg in hypertensive patients produced a mean additional decrease in supine systolic blood pressure of 8 mmHg and in diastolic blood pressure of 7 mmHg. [6] Patients on antihypertensives should have blood pressure monitored when tadalafil is added.

Riociguat (Absolute Contraindication)

Riociguat is a soluble guanylate cyclase stimulator used in PAH and chronic thromboembolic pulmonary hypertension. The FDA label states the combination with tadalafil is contraindicated because both drugs amplify the cGMP pathway, and concurrent use produced symptomatic hypotension in clinical studies. [1] This contraindication applies to the Adcirca (tadalafil 40 mg) formulation as well as Cialis. [7]

Can You Drink Alcohol on Cialis?

Alcohol and tadalafil both produce vasodilation and blood pressure reduction. The combination may cause additive hypotension, particularly in the upright position. Symptoms can include lightheadedness, dizziness, increased heart rate, and fainting. [1]

What the FDA Label Specifies

The prescribing information notes that tadalafil 0.7 g/kg alcohol (approximately five drinks in a 70-kg person) in combination with tadalafil 10 mg produced orthostatic hypotension in some subjects. [1] The label advises patients to avoid excessive alcohol. The specific language: "substantial consumption of alcohol (e.g., 5 units or greater) in combination with CIALIS can increase the potential for orthostatic signs and symptoms, including increase in heart rate, decrease in standing blood pressure, dizziness, and headache." [1]

Practical Guidance

Moderate alcohol, generally defined as one to two standard drinks, is unlikely to produce clinically significant hypotension in most patients on tadalafil. Patients with underlying cardiovascular disease, those on antihypertensives, or those taking alpha-blockers face greater risk from any alcohol use. Blood pressure should be stable before combining tadalafil with any quantity of alcohol. [8]

A 2002 pharmacokinetic study found that alcohol did not alter tadalafil plasma concentrations, meaning the interaction is pharmacodynamic (additive blood pressure lowering), not pharmacokinetic (altered drug levels). [6] This distinction matters because the interaction cannot be avoided by changing tadalafil timing relative to alcohol consumption.

Tadalafil in Special Populations: Interaction Considerations

Renal Impairment

Tadalafil clearance decreases as kidney function declines. In patients with creatinine clearance 31-50 mL/min, maximum recommended dose is 5 mg daily or 10 mg every 48 hours. For creatinine clearance <30 mL/min or patients on hemodialysis, once-daily dosing is not recommended, and on-demand dosing should be limited to 5 mg per dose. [1] This population is also more likely to receive pneumococcal and annual influenza vaccines per CDC guidelines, [9] but the vaccination itself requires no tadalafil adjustment.

Hepatic Impairment

In patients with Child-Pugh Class A or B hepatic impairment, maximum recommended dose is 10 mg every 24 hours for on-demand use. Child-Pugh Class C (severe hepatic impairment) has not been studied, and tadalafil use is not recommended. [1] Hepatic impairment alters CYP3A4 activity, which affects tadalafil metabolism, but this is unrelated to vaccination.

Older Adults

A pharmacokinetic study in men 65 years and older found that tadalafil AUC was 25% higher than in men aged 19-45, attributed to reduced renal clearance. [1] Older adults are the primary recipients of Shingrix (two-dose recombinant zoster vaccine, 97.2% efficacy against shingles in adults 50 years and older per the ZOSTER-006 trial, N=15,411) [10] and pneumococcal vaccines. No interaction with tadalafil is expected or documented for any of these vaccines.

Vaccine-Specific Considerations for Patients on Tadalafil

The table below summarizes routine adult vaccines and their interaction status with tadalafil, based on FDA label review and published pharmacology literature.

| Vaccine | Mechanism | Tadalafil Interaction | Clinical Action | |---|---|---|---| | Influenza (inactivated) | Inactivated antigen | None | Proceed normally | | COVID-19 mRNA (Pfizer, Moderna) | mRNA / spike protein | None | Proceed normally | | Shingrix (recombinant zoster) | Recombinant glycoprotein E | None | Proceed normally | | Prevnar 20 (pneumococcal) | Polysaccharide-protein conjugate | None | Proceed normally | | Tdap / Td | Toxoid / inactivated | None | Proceed normally | | Hepatitis B | Recombinant surface antigen | None | Proceed normally | | HPV (Gardasil 9) | Virus-like particle | None | Proceed normally | | Yellow fever (live attenuated) | Live attenuated virus | None pharmacological | Proceed; note any immunosuppression from comorbidities separately |

No vaccine in routine clinical use contains nitrates, CYP3A4 inhibitors, alpha-adrenergic blocking activity, or cGMP-modulating compounds. The pharmacological basis for a tadalafil-vaccine interaction does not exist. [2, 11]

A 2021 review in Drug Metabolism and Disposition evaluated cytokine-mediated CYP enzyme changes following COVID-19 mRNA vaccination and found that peak interferon-gamma and IL-6 elevations following vaccination were transient (24-48 hours) and insufficient to produce clinically meaningful CYP3A4 inhibition at vaccine doses approved for human use. [12] This finding extends the principle established in earlier influenza vaccine-drug interaction research. [5]

Post-Vaccination Symptoms vs. Tadalafil Side Effects: Telling Them Apart

Some post-vaccination side effects overlap with tadalafil adverse effects, which can cause patient confusion.

Shared Symptom Profile

Tadalafil commonly causes headache (reported in 14.5% of patients in on-demand trials), flushing (4.1%), and nasal congestion (4.3%). [1] COVID-19 mRNA vaccines commonly cause headache (55-60%), fatigue, and myalgia in the 24-48 hours after injection. [13] Influenza vaccines cause injection-site soreness, low-grade fever, and occasional headache. [9]

These overlapping symptoms do not represent an interaction. They are coincident adverse effect profiles from unrelated mechanisms.

When to Seek Care

Patients should contact their provider if they experience chest pain, significant blood pressure drop, or syncope within 24 hours of combining tadalafil with a new medication or activity. These symptoms suggest the cardiovascular interaction categories (nitrates, alpha-blockers, antihypertensives) rather than vaccination. [1]

Tadalafil Dosing Reference

For completeness, the approved dosing regimens for tadalafil per the FDA-approved label:

• Erectile dysfunction, on-demand: 10 mg taken before anticipated sexual activity; may adjust to 5 mg or 20 mg based on efficacy and tolerability. [1]
• Erectile dysfunction, once-daily: 2.5 mg once daily, may increase to 5 mg once daily. [1]
• BPH or ED/BPH combination: 5 mg once daily taken at approximately the same time each day. [1]
• Pulmonary arterial hypertension (Adcirca): 40 mg once daily. [7]

Starting dose reductions apply with strong CYP3A4 inhibitors and in renal or hepatic impairment as described above. [1]

Summary of Interaction Risk by Drug Class

The American Urological Association (AUA) 2018 guideline on erectile dysfunction classifies PDE5 inhibitor drug interactions by risk tier. [14] The AUA places nitrates in the absolute contraindication tier, alpha-blockers in the caution-with-dose-adjustment tier, and most other drug classes (including immunological agents) in the no-significant-interaction category.

The Endocrine Society's 2010 clinical practice guideline on male hypogonadism, which discusses PDE5 inhibitors in the context of testosterone therapy, contains no vaccine interaction warning for tadalafil in patients receiving concurrent hormone therapy. [15]

Both of these guideline bodies would be expected to flag a significant vaccine interaction if one were identified in the literature. Neither has done so.